Bright Minds Biosciences Inc.Bright Minds Biosciences Inc.Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

No trades
See on Supercharts

Price target

53.620.000.00%
The 1 analyst offering 1 year price forecasts for DRUG have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to DRUG in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


DRUG EPS for the last quarter is −0.44 USD despite the estimation of −0.44 USD. In the next quarter EPS is expected to reach −0.61 USD. Track more of Bright Minds Biosciences Inc. financials and stay on top of what is up with the company.
According to analysts, DRUG price target is 53.62 USD with a max estimate of 53.62 USD and a min estimate of 53.62 USD. Check if this forecast comes true in a year, meanwhile watch Bright Minds Biosciences Inc. stock price chart and keep track of the current situation with DRUG news and stock market news.